TIDMBYOT

RNS Number : 2149R

Byotrol PLC

07 December 2016

7 December 2016

Byotrol plc

("Byotrol" or the "Company")

Notice of Interim Results

The Company announces that it will be releasing its interim results for the six months ended 30 September 2016 on Tuesday 13 December 2016.

Enquiries:

 
 Byotrol plc                        01925 742 000 
 David Traynor - Chief Executive 
 
   finnCap Ltd                        020 7220 0500 
 (Nominated Adviser & Broker) 
 Geoff Nash/Carl Holmes/James 
  Thompson - Corporate Finance 
 Mia Gardner - Corporate Broking

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist in developing, formulating and commercialising cutting-edge antimicrobial technologies.

Our patented suite of technologies delivers powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.

For more information, please go to www.byotrol.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORBDBDDIDGBGLR

(END) Dow Jones Newswires

December 07, 2016 07:29 ET (12:29 GMT)

Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Byotrol Charts.
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Byotrol Charts.